[1] G. Y. Lip, B. S. Chin and A. D. Blann, “Cancer and the Prothrombotic State,” The Lancet Oncology, Vol. 3, No. 1, 2002, pp. 27-34. doi:10.1016/S1470-2045(01)00619-2
[2] A. A. Khorana and R. L. Fine, “Pancreatic Cancer and Thromboembolic Disease,” The Lancet Oncology, Vol. 5, No. 11, 2004, pp. 655-663. doi:10.1016/S1470-2045(04)01606-7
[3] A. Varki, “Trousseau’s Syndrome: Multiple Definitions and Multiple Mechanisms,” Blood, Vol. 110, No. 6, 2007, pp. 1723-1729. doi:10.1182/blood-2006-10-053736
[4] L. R. Rogers, “Cerebrovascular Complications in Cancer Patients,” Neurologic Clinics, Vol. 21, No.1, 2003, pp. 167-192. doi:10.1016/S0733-8619(02)00066-X
[5] E. E. Rigdon, “Trousseau’s Syndrome and Acute Arterial Thrombosis,” Journal of Cardiovascular Surgery, Vol. 8, No. 3, 2000, pp. 214-218.
[6] S. Giray, B. F. Sarica, Z. Arlier and N. Bal, “Recurrent Ischemic Stroke as an Initial Manifestation of an Concealed Pancreatic Adenocarcinoma: Trousseau’s Syndrome,” Chinese Medical Journal, Vol. 124, No. 4, 2011, pp. 637-640.
[7] R. Clarke, J. Halsey, D. Bennett and S. Lewington, “Homocysteine and Vascular Disease: Review of Published Results of the Homocysteine-Lowering Trials,” Journal of Inherited Metabolic Disease, Vol. 34, No. 1, 2011, pp. 83-91. doi:10.1007/s10545-010-9235-y
[8] O. Y. Bang, J. M. Seok, S. G. Kim, J. M. Hong, H. Y. Kim, J. Lee, P. W. Chung, K. Y. Park, G. M. Kim, C. S. Chung and K. H. Lee, “Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes,” Journal of Clinical Neurology, Vol. 7, No. 2, 2011, pp. 53-59. doi:10.3988/jcn.2011.7.2.53
[9] P. J. Saylor and A. E. Fogerty, “Prostate-Cancer-Associated Hypercoagulability: Do We Need to Worry about Androgen Deprivation?” The Lancet Oncology, Vol. 11, No. 5, 2010, pp. 406-407. doi:10.1016/S1470-2045(10)70063-2